Publication:
Intravenous tPA Administration in Patients With Acute Ischemic Stroke: Edirne Experience

Simple item page
dc.contributor.authorAsil, TALİP
dc.contributor.authorBalci, Kemal
dc.contributor.authorUtku, Ufuk
dc.contributor.authorIr, Nasif
dc.contributor.institutionauthorASİL, TALIP
dc.date.accessioned2020-10-29T21:26:41Z
dc.date.available2020-10-29T21:26:41Z
dc.date.issued2011-01-01T00:00:00Z
dc.description.abstractObjective: Intravenous (IV) thrombolytic therapy is the only approved effective treatment used in patients with acute ischemic stroke. In this study, we aimed at establishing the clinical outcomes of the IV tissue plasminogen activator (tPA) therapy and the main factors affecting the success rate of the treatment.
dc.identifier.citationAsil T., Balci K., Utku U., Ir N., -Intravenous tPA Administration in Patients With Acute Ischemic Stroke: Edirne Experience-, JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.28, ss.317-321, 2011
dc.identifier.scopus80052753581
dc.identifier.trdizintrdizin
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26282
dc.identifier.wosWOS:000298031700003
dc.titleIntravenous tPA Administration in Patients With Acute Ischemic Stroke: Edirne Experience
dc.typeArticle
dspace.entity.typePublication
local.avesis.id8890ddde-afee-479c-b01c-4f8dc8ba3348
local.publication.isinternational1
relation.isAuthorOfPublicationd6d2b335-cf30-4de8-b2c6-9d158f661759
relation.isAuthorOfPublication.latestForDiscoveryd6d2b335-cf30-4de8-b2c6-9d158f661759

Files

Collections

Yayınlar - Eserler
TR Dizin İndeksli Yayınlar Koleksiyonu